Cardiovascular Risk Factors in Middle Eastern Patients With Stroke
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorJordan Collaborating Cardiology Group
About this trial
Stroke is a well-known a leading cause of death and disability in the Middle East. There remain many knowledge gaps in evaluating the prevalence of risk factors among patients with stroke in the Middle East. Unravelling the impact of these risk factors and controlling them can positively lower the incidence of stroke. Disparities in stroke risk factors, may well be related to ethnicity of the Middle Eastern populations , will be compared with those among stroke patients in the western literature.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Diagnosis of stroke upon admission to the hospital
Adult aged 18 years or older
Available lipid profile on hospital admission
Disqualifiers
Stroke diagnosis unconfirmed
age younger than 18 years
No available lipid profile on admission
Trial population
Will enroll adults admitted to the hospital with a working diagnosis of stroke and then the diagnosis is confirmed by a neurologist. Patients ii be interviewed for data collection of 4 risk factors as above in addition to the serum level of LDLC and the use of lipid lowering agents.
Trial design
Design model
Case-only
Time perspective
Retrospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Prevalence of hypertension in stroke patients (survey interview)
BP more 140/90 or known diagnosis of high blood pressure or patient already on blood pressure medication
Time frame
Baseline2
Prevalence of type 2 diabetes in stroke patients (survey interview)
HbA1c more than 6.5%, or known diagnosis of type 2 diabetes or patient already on anti diabetes medications
Time frame
BASELINE3
Prevalence of elevated serum level of low density lipoprotein cholesterol in stroke patients (survey interview)
Elevated serum level of low density lipoprotein cholesterol \> 55 mg/dl or patient already on lipid lowering medication
Time frame
BASELINE4
Prevalence of current cigarette smoking in stroke patients (survey interview)
Known current cigarette smoking of any number of cigarettes per day
Time frame
BASELINESponsors and contacts
Click on the lead sponsor to view all of their trials.
Source ClinicalTrials.gov
This trial is not recruiting at the moment. You can still explore other options: